Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Background. The infertility caused by polycystic ovary syndrome (PCOS) has received considerable attention. Considerable efforts have been made to improve the rates of pregnancy and live birth. Cangfu Daotan Decoction (CFDTD) is a classic prescription for treating infertility in obese women. The eff...
Gespeichert in:
| Veröffentlicht in: | Evidence-based complementary and alternative medicine 2022, Vol.2022, p.4395612-13 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 13 |
|---|---|
| container_issue | |
| container_start_page | 4395612 |
| container_title | Evidence-based complementary and alternative medicine |
| container_volume | 2022 |
| creator | Wu, Linling Zhang, Han Fan, Mengxiao Yan, Ying |
| description | Background. The infertility caused by polycystic ovary syndrome (PCOS) has received considerable attention. Considerable efforts have been made to improve the rates of pregnancy and live birth. Cangfu Daotan Decoction (CFDTD) is a classic prescription for treating infertility in obese women. The efficacy of CFDTD in PCOS is controversial. Objective. To evaluate the effectiveness and safety of CFDTD in treating infertility with PCOS. Methods. A literature search was performed in the Cochrane Library, PubMed, Embase, the China National Knowledge Infrastructure, the Wanfang Database, the VIP Chinese Biomedical science journal database, and the Chinese BioMedical database from the date of each database establishment to December 2021. Only randomized controlled trials, which were used to evaluate the efficacy of CFDTD in treating subjects with PCOS, were included in the present study. The quality of evidence was assessed using the Cochrane Reviewer Handbook 5.0.0, and meta-analysis was performed using RevMan 5.3.5 software. Results. Fourteen studies with a total of 1,433 patients were included in this analysis. The present study indicated that CFDTD could significantly improve pregnancy rate (RR = 1.62, 95% CI (1.44, 1.83), P |
| doi_str_mv | 10.1155/2022/4395612 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9129968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2691055565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3202-707d3db550e5ca73619ea0b610e757f3095ec5b46f97e5ff3e4b7bc782d8e8d43</originalsourceid><addsrcrecordid>eNp9kc1v1DAQxS0EoqVw44wscUGCUH_EccIBabUtH1JRKwoSN8txxl1XiV1iZ1e58afjZZcVcOA0I81Pb97TQ-gpJa8pFeKUEcZOS96IirJ76JjKkhYlq-v7h11-O0KPYrwlhDVSyofoiIuKkZKSY_Tj3FpntJmx9h2-1hbSjIPFS-1v7ITPdEja4zMwwSQXPHYeX-nkwKeINy6t8FXoZzPH5Ay-XOtxxtez78YwwBu8yHtMMOjt8TOsHWx-ffkESRcLr_s5uvgYPbC6j_BkP0_Q13fnX5YfiovL9x-Xi4vC8JywkER2vGuFICCMlryiDWjSVpSAFNJy0ggwoi0r20gQ1nIoW9kaWbOuhror-Ql6u9O9m9oBOpMTjLpXd6MbsmsVtFN_X7xbqZuwVg1lTVPVWeDFXmAM3yeISQ0uGuh77SFMUbGqoUQIUYmMPv8HvQ3TmANvKUmzV1bxTL3aUWYMMY5gD2YoUdtq1bZata8248_-DHCAf3eZgZc7YOV8pzfu_3I_AerkrIM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671095263</pqid></control><display><type>article</type><title>Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wu, Linling ; Zhang, Han ; Fan, Mengxiao ; Yan, Ying</creator><contributor>Zhang, Yue Hui ; Yue Hui Zhang</contributor><creatorcontrib>Wu, Linling ; Zhang, Han ; Fan, Mengxiao ; Yan, Ying ; Zhang, Yue Hui ; Yue Hui Zhang</creatorcontrib><description><![CDATA[Background. The infertility caused by polycystic ovary syndrome (PCOS) has received considerable attention. Considerable efforts have been made to improve the rates of pregnancy and live birth. Cangfu Daotan Decoction (CFDTD) is a classic prescription for treating infertility in obese women. The efficacy of CFDTD in PCOS is controversial. Objective. To evaluate the effectiveness and safety of CFDTD in treating infertility with PCOS. Methods. A literature search was performed in the Cochrane Library, PubMed, Embase, the China National Knowledge Infrastructure, the Wanfang Database, the VIP Chinese Biomedical science journal database, and the Chinese BioMedical database from the date of each database establishment to December 2021. Only randomized controlled trials, which were used to evaluate the efficacy of CFDTD in treating subjects with PCOS, were included in the present study. The quality of evidence was assessed using the Cochrane Reviewer Handbook 5.0.0, and meta-analysis was performed using RevMan 5.3.5 software. Results. Fourteen studies with a total of 1,433 patients were included in this analysis. The present study indicated that CFDTD could significantly improve pregnancy rate (RR = 1.62, 95% CI (1.44, 1.83), P<0.00001), ovulation rate (RR = 1.40, 95% CI (1.25, 1.56), P<0.00001), and estradiol levels (SMD = 0.80, 95% CI (0.03, 1.58), P=0.04), while testosterone levels (SMD = −0.92, 95% CI (−1.52, −0.31), P=0.003), homeostatic model assessment for insulin resistance (MD = −0.56, 95% CI (−0.99, −0.12), P=0.01), total cholesterol levels (MD = −0.60, 95% CI (−0.76, −0.44), P<0.00001), triglyceride levels (MD = −0.48, 95% CI (−0.60, −0.36), P<0.00001), body mass index (MD = −2.96, 95% CI (−3.88, −2.03), P<0.00001), and the incidence of adverse reactions (RR = 0.47, 95% CI (0.34, 0.65), P<0.00001) were significantly reduced. Conclusions. Evidence from the meta-analysis suggested that CFDTD appeared to be an effective and relatively safe treatment for PCOS. However, the influence of CFDTD on reproductive hormones, glucose metabolism, and blood lipids should be carefully concluded. Due to the low quality of the methods used in the included randomized controlled trials, further studies are required with larger sample sizes and well-designed models to confirm our findings.]]></description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2022/4395612</identifier><identifier>PMID: 35620410</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>17β-Estradiol ; Body mass index ; Cholesterol ; Clinical trials ; Glucose metabolism ; Infertility ; Insulin ; Insulin resistance ; Lipid metabolism ; Meta-analysis ; Obesity ; Ovaries ; Ovulation ; Patients ; Polycystic ovary syndrome ; Pregnancy ; Systematic review ; Testosterone</subject><ispartof>Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.4395612-13</ispartof><rights>Copyright © 2022 Linling Wu et al.</rights><rights>Copyright © 2022 Linling Wu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Linling Wu et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3202-707d3db550e5ca73619ea0b610e757f3095ec5b46f97e5ff3e4b7bc782d8e8d43</cites><orcidid>0000-0002-7293-4190 ; 0000-0002-9887-2231 ; 0000-0003-2495-1524 ; 0000-0003-1560-4627</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129968/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129968/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,887,4026,27930,27931,27932,53798,53800</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35620410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Zhang, Yue Hui</contributor><contributor>Yue Hui Zhang</contributor><creatorcontrib>Wu, Linling</creatorcontrib><creatorcontrib>Zhang, Han</creatorcontrib><creatorcontrib>Fan, Mengxiao</creatorcontrib><creatorcontrib>Yan, Ying</creatorcontrib><title>Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description><![CDATA[Background. The infertility caused by polycystic ovary syndrome (PCOS) has received considerable attention. Considerable efforts have been made to improve the rates of pregnancy and live birth. Cangfu Daotan Decoction (CFDTD) is a classic prescription for treating infertility in obese women. The efficacy of CFDTD in PCOS is controversial. Objective. To evaluate the effectiveness and safety of CFDTD in treating infertility with PCOS. Methods. A literature search was performed in the Cochrane Library, PubMed, Embase, the China National Knowledge Infrastructure, the Wanfang Database, the VIP Chinese Biomedical science journal database, and the Chinese BioMedical database from the date of each database establishment to December 2021. Only randomized controlled trials, which were used to evaluate the efficacy of CFDTD in treating subjects with PCOS, were included in the present study. The quality of evidence was assessed using the Cochrane Reviewer Handbook 5.0.0, and meta-analysis was performed using RevMan 5.3.5 software. Results. Fourteen studies with a total of 1,433 patients were included in this analysis. The present study indicated that CFDTD could significantly improve pregnancy rate (RR = 1.62, 95% CI (1.44, 1.83), P<0.00001), ovulation rate (RR = 1.40, 95% CI (1.25, 1.56), P<0.00001), and estradiol levels (SMD = 0.80, 95% CI (0.03, 1.58), P=0.04), while testosterone levels (SMD = −0.92, 95% CI (−1.52, −0.31), P=0.003), homeostatic model assessment for insulin resistance (MD = −0.56, 95% CI (−0.99, −0.12), P=0.01), total cholesterol levels (MD = −0.60, 95% CI (−0.76, −0.44), P<0.00001), triglyceride levels (MD = −0.48, 95% CI (−0.60, −0.36), P<0.00001), body mass index (MD = −2.96, 95% CI (−3.88, −2.03), P<0.00001), and the incidence of adverse reactions (RR = 0.47, 95% CI (0.34, 0.65), P<0.00001) were significantly reduced. Conclusions. Evidence from the meta-analysis suggested that CFDTD appeared to be an effective and relatively safe treatment for PCOS. However, the influence of CFDTD on reproductive hormones, glucose metabolism, and blood lipids should be carefully concluded. Due to the low quality of the methods used in the included randomized controlled trials, further studies are required with larger sample sizes and well-designed models to confirm our findings.]]></description><subject>17β-Estradiol</subject><subject>Body mass index</subject><subject>Cholesterol</subject><subject>Clinical trials</subject><subject>Glucose metabolism</subject><subject>Infertility</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Lipid metabolism</subject><subject>Meta-analysis</subject><subject>Obesity</subject><subject>Ovaries</subject><subject>Ovulation</subject><subject>Patients</subject><subject>Polycystic ovary syndrome</subject><subject>Pregnancy</subject><subject>Systematic review</subject><subject>Testosterone</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc1v1DAQxS0EoqVw44wscUGCUH_EccIBabUtH1JRKwoSN8txxl1XiV1iZ1e58afjZZcVcOA0I81Pb97TQ-gpJa8pFeKUEcZOS96IirJ76JjKkhYlq-v7h11-O0KPYrwlhDVSyofoiIuKkZKSY_Tj3FpntJmx9h2-1hbSjIPFS-1v7ITPdEja4zMwwSQXPHYeX-nkwKeINy6t8FXoZzPH5Ay-XOtxxtez78YwwBu8yHtMMOjt8TOsHWx-ffkESRcLr_s5uvgYPbC6j_BkP0_Q13fnX5YfiovL9x-Xi4vC8JywkER2vGuFICCMlryiDWjSVpSAFNJy0ggwoi0r20gQ1nIoW9kaWbOuhror-Ql6u9O9m9oBOpMTjLpXd6MbsmsVtFN_X7xbqZuwVg1lTVPVWeDFXmAM3yeISQ0uGuh77SFMUbGqoUQIUYmMPv8HvQ3TmANvKUmzV1bxTL3aUWYMMY5gD2YoUdtq1bZata8248_-DHCAf3eZgZc7YOV8pzfu_3I_AerkrIM</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Wu, Linling</creator><creator>Zhang, Han</creator><creator>Fan, Mengxiao</creator><creator>Yan, Ying</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7293-4190</orcidid><orcidid>https://orcid.org/0000-0002-9887-2231</orcidid><orcidid>https://orcid.org/0000-0003-2495-1524</orcidid><orcidid>https://orcid.org/0000-0003-1560-4627</orcidid></search><sort><creationdate>2022</creationdate><title>Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis</title><author>Wu, Linling ; Zhang, Han ; Fan, Mengxiao ; Yan, Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3202-707d3db550e5ca73619ea0b610e757f3095ec5b46f97e5ff3e4b7bc782d8e8d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>17β-Estradiol</topic><topic>Body mass index</topic><topic>Cholesterol</topic><topic>Clinical trials</topic><topic>Glucose metabolism</topic><topic>Infertility</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Lipid metabolism</topic><topic>Meta-analysis</topic><topic>Obesity</topic><topic>Ovaries</topic><topic>Ovulation</topic><topic>Patients</topic><topic>Polycystic ovary syndrome</topic><topic>Pregnancy</topic><topic>Systematic review</topic><topic>Testosterone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Linling</creatorcontrib><creatorcontrib>Zhang, Han</creatorcontrib><creatorcontrib>Fan, Mengxiao</creatorcontrib><creatorcontrib>Yan, Ying</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Linling</au><au>Zhang, Han</au><au>Fan, Mengxiao</au><au>Yan, Ying</au><au>Zhang, Yue Hui</au><au>Yue Hui Zhang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2022</date><risdate>2022</risdate><volume>2022</volume><spage>4395612</spage><epage>13</epage><pages>4395612-13</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract><![CDATA[Background. The infertility caused by polycystic ovary syndrome (PCOS) has received considerable attention. Considerable efforts have been made to improve the rates of pregnancy and live birth. Cangfu Daotan Decoction (CFDTD) is a classic prescription for treating infertility in obese women. The efficacy of CFDTD in PCOS is controversial. Objective. To evaluate the effectiveness and safety of CFDTD in treating infertility with PCOS. Methods. A literature search was performed in the Cochrane Library, PubMed, Embase, the China National Knowledge Infrastructure, the Wanfang Database, the VIP Chinese Biomedical science journal database, and the Chinese BioMedical database from the date of each database establishment to December 2021. Only randomized controlled trials, which were used to evaluate the efficacy of CFDTD in treating subjects with PCOS, were included in the present study. The quality of evidence was assessed using the Cochrane Reviewer Handbook 5.0.0, and meta-analysis was performed using RevMan 5.3.5 software. Results. Fourteen studies with a total of 1,433 patients were included in this analysis. The present study indicated that CFDTD could significantly improve pregnancy rate (RR = 1.62, 95% CI (1.44, 1.83), P<0.00001), ovulation rate (RR = 1.40, 95% CI (1.25, 1.56), P<0.00001), and estradiol levels (SMD = 0.80, 95% CI (0.03, 1.58), P=0.04), while testosterone levels (SMD = −0.92, 95% CI (−1.52, −0.31), P=0.003), homeostatic model assessment for insulin resistance (MD = −0.56, 95% CI (−0.99, −0.12), P=0.01), total cholesterol levels (MD = −0.60, 95% CI (−0.76, −0.44), P<0.00001), triglyceride levels (MD = −0.48, 95% CI (−0.60, −0.36), P<0.00001), body mass index (MD = −2.96, 95% CI (−3.88, −2.03), P<0.00001), and the incidence of adverse reactions (RR = 0.47, 95% CI (0.34, 0.65), P<0.00001) were significantly reduced. Conclusions. Evidence from the meta-analysis suggested that CFDTD appeared to be an effective and relatively safe treatment for PCOS. However, the influence of CFDTD on reproductive hormones, glucose metabolism, and blood lipids should be carefully concluded. Due to the low quality of the methods used in the included randomized controlled trials, further studies are required with larger sample sizes and well-designed models to confirm our findings.]]></abstract><cop>United States</cop><pub>Hindawi</pub><pmid>35620410</pmid><doi>10.1155/2022/4395612</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-7293-4190</orcidid><orcidid>https://orcid.org/0000-0002-9887-2231</orcidid><orcidid>https://orcid.org/0000-0003-2495-1524</orcidid><orcidid>https://orcid.org/0000-0003-1560-4627</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1741-427X |
| ispartof | Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.4395612-13 |
| issn | 1741-427X 1741-4288 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9129968 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
| subjects | 17β-Estradiol Body mass index Cholesterol Clinical trials Glucose metabolism Infertility Insulin Insulin resistance Lipid metabolism Meta-analysis Obesity Ovaries Ovulation Patients Polycystic ovary syndrome Pregnancy Systematic review Testosterone |
| title | Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-07T21%3A40%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20Safety%20of%20Cangfu%20Daotan%20Decoction%20in%20Patients%20with%20Polycystic%20Ovary%20Syndrome:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Wu,%20Linling&rft.date=2022&rft.volume=2022&rft.spage=4395612&rft.epage=13&rft.pages=4395612-13&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2022/4395612&rft_dat=%3Cproquest_pubme%3E2691055565%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2671095263&rft_id=info:pmid/35620410&rfr_iscdi=true |